CORDIS - EU research results

Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients



Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma

Author(s): Erik H. van Beers, Daphne Huigh, Lizanne Bosman, Leonie de Best, Rowan Kuiper, Marieke Spaan, Mark van Duin, Pieter Sonneveld, Belinda Dumee, Martin H. van Vliet
Published in: The Journal of Molecular Diagnostics, Issue Online ahead of print., 2020, Page(s) Online ahead of print., ISSN 1525-1578
Publisher: American Society for Investigative Pathology
DOI: 10.1016/j.jmoldx.2020.10.010

Prognostic and Predictive Performance of SKY92 Combined with R-ISS in Elderly Multiple Myeloma Patients in The Hovon-87/NMSG-18 Study

Author(s): Rowan Kuiper, Annemiek Broijl, Mark van Duin, Martin H. van Vliet, Mark-David Levin, Erik H. van Beers, Bronno Van der Holt, Heleen Visser, Markus Hansson, Annette W.G. van der Velden, Belinda Dumee, Michael Vermeulen, Jasper Koenders, H. Berna Beverloo, Marian Stevens-Kroef, Pieter Sonneveld, Anders Waage, Sonja Zweegman
Published in: Clinical Lymphoma Myeloma and Leukemia, Issue 19/10, 2019, Page(s) e10-e11, ISSN 2152-2650
Publisher: Elsevier
DOI: 10.1016/j.clml.2019.09.014

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available